‘Paying Twice’: A Push for Affordable Prices for Taxpayer-Funded Drugs

on
The National Institutes of Health is helping to develop more cutting-edge drugs. But the agency says its mission doesn’t include evaluating prices, even when the drugs use breakthroughs it patented.

from news https://ift.tt/2kv51kN
via NYT Repost by newstimeweb